LKT Laboratories, Inc.

LKT Laboratories, Inc. logo

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Imiquimod 100 mg  | ≥99.5%

LKT Laboratories, Inc.

Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.

More Information Supplier Page

Imiquimod 500 mg  | ≥99.5%

LKT Laboratories, Inc.

Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.

More Information Supplier Page

Imiquimod 1 g  | ≥99.5%

LKT Laboratories, Inc.

Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.

More Information Supplier Page

Imiquimod 5 g  | ≥99.5%

LKT Laboratories, Inc.

Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.

More Information Supplier Page

Inositol 100 g  | ≥98%

LKT Laboratories, Inc.

Endogenous sugar produced from glucose, required for production of IMP and phosphatidyl inositol.

More Information Supplier Page

Inositol 500 g  | ≥98%

LKT Laboratories, Inc.

Endogenous sugar produced from glucose, required for production of IMP and phosphatidyl inositol.

More Information Supplier Page